Fonds-News

CARMIEL, Israel, Jan. 5, 2026 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced the following update from President and Chief Executive Officer, Dror Bashan, to its stockholders.…

Corgi lists its Founder-Led ETF on Nasdaq to provide diversified, rules-based founder-led exposure. NEW YORK, Jan. 5, 2026 /PRNewswire/ — Corgi, an AI fintech startup, announced the launch and Nasdaq listing of Corgi’s Founder-Led ETF (Nasdaq: FDRS), an exchange-traded fund designed to provide investors with a simple way to gain…